Lieselot Carrette

Title: Lieselot Carrette: Innovator in Gene Reactivation

Introduction

Lieselot Carrette is a prominent inventor based in Beernem, Belgium. She has made significant contributions to the field of genetics, particularly in the area of gene reactivation. With a total of four patents to her name, her work is paving the way for advancements in genetic research and therapies.

Latest Patents

Lieselot Carrette's latest patents focus on innovative methods for reactivating genes on the inactive X chromosome. These methods include administering one or both of a DNA methyltransferase (DNMT) inhibitor and/or a topoisomerase inhibitor, such as etoposide and/or 5′-azacytidine (aza). Additionally, her patents explore the use of inhibitors of XIST RNA and/or Xist-interacting proteins, which may include chromatin-modifying proteins, small molecules, or inhibitory nucleic acids like small inhibitory RNA (siRNAs) or antisense oligonucleotides (ASOs) that target XIST RNA and genes encoding Xist-interacting proteins.

Career Highlights

Throughout her career, Lieselot Carrette has worked with esteemed institutions, including Ghent University and The General Hospital Corporation. Her research has garnered attention for its potential applications in treating genetic disorders and enhancing our understanding of gene regulation.

Collaborations

Lieselot has collaborated with notable colleagues such as Annemieke Madder and Kurt Hoogewijs, contributing to a rich exchange of ideas and expertise in her field.

Conclusion

Lieselot Carrette's innovative work in gene reactivation represents a significant advancement in genetic research. Her contributions are likely to have a lasting impact on the field and open new avenues for therapeutic interventions.